PET/MR在口腔颌面部恶性肿瘤外科手术中的应用价值

吴中明; 李云波; 王维戚; 魏建华

doi:10.12122/j.issn.1674-4500.2020.01.09

PET/MR在口腔颌面部恶性肿瘤外科手术中的应用价值

doi: 10.12122/j.issn.1674-4500.2020.01.09

1.
军事口腔医学国家重点实验室//口腔疾病国家临床医学研究中心//陕西省口腔疾病临床医学研究中心，陕西西安 710032
2.
空军军医大学第二附属医院核医学科，陕西西安 710038

详细信息

作者简介:
吴中明，博士研究生，住院医师，E-mail：1512649468@qq.com

通讯作者:
魏建华，博士，副主任医师，副教授，E-mail：64265919@qq.com

计量
- 文章访问数: 1241
- HTML全文浏览量: 528
- PDF下载量: 100
- 被引次数: 0
出版历程
- 收稿日期: 2020-01-03
- 刊出日期: 2020-01-01

Application value of PET/MR in surgery of Oral and Maxillofacial malignant tumors

1.
State Key Laboratory of Military Stomatology / National Clinical Research Center for Oral Diseases / Shaanxi Clinical Research Center for Oral Diseases, Department of Oral and Maxillofacial Surgery, School of Stomatology, the Fourth Military Medical University, Xi`an 710032, China
2.
Department of Nuclear Medicine, Second Affiliated Hospital of Air Force Military Medical University, Xi`an 710038, China

摘要

摘要: 近年来口腔颌面部肿瘤发病率呈逐年上升趋势，外科手术仍是目前口腔颌面部肿瘤的重要治疗手段，手术方案的制定及术后预后取决于癌肿的大小、侵犯范围、是否伴有淋巴结转移及远处转移。影像学检查在口腔颌面部肿瘤的术前评估中发挥着越来越重要的作用，PET/MR为目前国际上最先进的分子影像学设备，结构与功能影像的完美结合，在肿瘤的诊断及指导治疗中发挥着不可或缺的作用，但其在口腔颌面部肿瘤中的临床应用价值鲜有报道，该综述的目的在于通过临床病例结合国内外相关文献探讨PET/MR在口腔颌面部肿瘤中术前评估与术后疗效的应用价值。
- PET/MR /
- 口腔颌面部 /
- 恶性肿瘤 /
- 手术
Abstract: The incidence of oral and maxillofacial tumors was increased year by year. Surgery is still an important treatment at present. The surgical plan and postoperative prognosis depend on the size of cancer, the extent of invasion,whether accompanied by lymph node metastasis and distant metastasis. Imaging examination plays a more and more important role in the preoperative evaluation in patient with oral and maxillofacial tumors. PET/MR is the most advanced molecular imaging equipment in the world, the perfect combination of structure and functional imaging plays an indispensable role in the diagnosis and treatment of tumors, but its clinical application value in oral and maxillofacial tumors is rarely reported. The purpose of this review is to explore the application value of PET/MR in oral and maxillofacial tumors through clinical cases combined with relevant literature at home and abroad.
- PET/MR /
- oral and maxillofacial /
- malignant tumors /
- surgery

HTML全文

参考文献(31)

[1]	Afzali P, Ward BB. Management of the neck in oral squamous cell carcinoma[J]. Oral Maxillofac Surg Clin North Am, 2019, 31(3): 69-84.
[2]	Kitamoto E, Chikui T, Kawano S, et al. The application of dynamic contrast-enhanced MRI and diffusion-weighted MRI in patients with maxillofacial tumors[J]. Acad Radiol, 2015, 22(4): 210-6.
[3]	Asaumi J, Yanagi Y, Hisatomi M, et al. The value of dynamic contrastenhanced MRI in diagnosis of malignant lymphoma of the head and neck[J]. Eur J Radiol, 2003, 48(2): 183-7. doi: 10.1016/S0720-048X(02)00347-9
[4]	杜燕飞, 滕建波, 李传亭. 超声弹性成像在腮腺肿瘤诊断中的研究进展[J]. 医学影像学杂志, 2014, 24(5): 484-6.
[5]	De BR, Castelijns JA, Hokestra OS, et al. Advances in imaging in the work-up of head and neck cancer patients[J]. Oral Oncol, 2009, 45(10): 930-5.
[6]	Hisatomi M, Asaumi J, Yanagi Y, et al. Diagnostic value of dynamic contrast-enhanced MRI in the salivary gland tumors[J]. Oral Oncol, 2007, 43(12): 940-7.
[7]	Eida S, Sumi M, Nakamura T. Multiparametric magnetic resonance imaging for the differentiation between benign and malignant salivary gland tumors[J]. J Magn Reson Imaging, 2010, 31(8): 673-9.
[8]	Matsuzaki H, Yanagi Y, Hara M, et al. Minor salivary gland tumors in the oral cavity: diagnostic value of dynamic contrast-enhanced MRI[J]. Eur J Radiol, 2012, 81(13): 2684-91.
[9]	Lombardi D, Accorona R, Lambert A, et al. Long-term outcomes and prognosis in submandibular gland malignant tumors: a multicenter study[J]. Laryngoscope, 2018, 128(15): 2745-50.
[10]	Singh D, Sahoo S, Gupta V, et al. Latest advancements in imaging of oral and maxillofacial neoplasm: a comprehensive review[J]. J Oral Maxillofac Radiol, 2013, 20(1): 37-42.
[11]	Adelstein D, Gillison ML, Pfister DG, et al. NCCN guidelines insights: head and neck cancers, version 2[J]. J Natl Compr Cancer Netw, 2017, 15(9): 761-70.
[12]	Ng SH, Chan SC, Yen TC, et al. Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work-up[J]. Eur J Nucl Med Mol Imaging, 2009, 36(1): 12-22. doi: 10.1007/s00259-008-0918-7
[13]	Chan SC, Yeh CH, Yen TC, et al. Clinical utility of simultaneous whole-body 18F-FDG PET/MRI as a single-step imaging modality in the staging of primary nasopharyngeal carcinoma[J]. Europ J Nuclear Med Molecul Imaging, 2018, 45(10): 1297-308.
[14]	Roh JL, Yeo NK, Kim JS, et al. Utility of 18F-FDG PET/CT in the preoperative staging of head and neck squamous cell carcinoma[J]. Oral Oncol, 2007, 43(12): 887-93.
[15]	Ming HM, Shu W, Zhi-en F, et al. Accuracy of magnetic resonance imaging in evaluating the depth of invasion of tongue cancer: a prospective cohort study[J]. Oral Oncol, 2019, 91(2): 79-84.
[16]	Ling W, Mijiti A, Moming A. Survival pattern and prognostic factors of patients with squamous cell carcinoma of the tongue: a retrospective analysis of 210 cases[J]. J Oral Maxillofac Surg, 2013, 71(13): 775-85.
[17]	Yesuratnam A, Wiesenfeld D, Tsui A, et al. Preoperative evaluation of oral tongue squamous cell carcinoma with intraoral ultrasound and magnetic resonance imaging-comparison with histopathological tumour thickness and accuracy in guiding patient management[J]. Int J Oral Maxillofac Surg, 2014, 43(22): 787-94.
[18]	方言成, 李亚辉. 磁共振对老年人口腔颌面部肿瘤的诊断价值[J]. 中国老年学杂志, 2013, 10(9): 5151-2.
[19]	周泉. 口腔颌面部恶性肿瘤术后短期复发的相关因素分析[J]. 中国社区医师, 2009, 18(3): 145-56.
[20]	National Comprehensive Cancer Network. NCCN clinical practice guidelines: head and neck cancers, version 12017[M]. Ft. Washington, PA: NCCN, 2017.
[21]	Goel R, Moore W, Sumer B, et al. Clinical Practice in PET/CT for the management of head and neck squamous cell cancer[J]. Am J Roentgenol, 2017, 209(4): 289-303.
[22]	Zhu L, Wang N. 18F-fluorodeoxyglucose positron emission tomography-computed tomography as a diagnostic tool in patients with cervical nodal metastases of unknown primary site: a meta-analysis[J]. Surg Oncol, 2013, 22(3): 190-4. doi: 10.1016/j.suronc.2013.06.002
[23]	胡小巧, 郭炳君, 陈晓品. PET/CT在恶性肿瘤治疗后评价中的作用与局限性[J]. 现代肿瘤学, 2015, 16(12): 2239-42.
[24]	Yamamoto Y, Wong TZ, Turkington TG, et al. Head and neck cancer: dedicated FDG PET/CT protocol for detection-phantom and initial clinical studies[J]. Radiology, 2007, 244(10): 263-72.
[25]	Li Z, Han C, Wang L, et al. Prognostic value of texture analysis based on pretreatment DWI-weighted MRI for esophageal squamous cell carcinoma patients treated with concurrent chemo-radiotherapy[J]. Front Oncol, 2019, 17(16): 1057-68.
[26]	Tezcan Ş, Uslu N, Öztürk FU, et al. Diffusion-weighted imaging of breast cancer: correlation of the apparent diffusion coefficient value with pathologic prognostic factors[J]. Eur J Breast Health, 2019, 15(3): 262-7.
[27]	Hayashi K, Kikuchi M, Imai Y, et al. Clinical value of fused PET/MRI for surgical planning in patients with oral/oropharyngeal carcinoma[J]. Laryngoscope, 2019, 49(121): 27911-23.
[28]	Catalano OA, Nicolai E, Rosen BR, et al. Comparison of CE-FDG-PET/CT with CE-FDG-PET/MR in the evaluation of osseous metastases in breast cancer patients[J]. Br J Cancer, 2015, 112(9): 1452-60. doi: 10.1038/bjc.2015.112
[29]	Cavaliere C, Romeo V, Aiello M, et al. Multiparametric evaluation by simultaneous PET-MRI examination in patients with histologically proven laryngeal cancer[J]. Eur J Radiol, 2017, 88(2): 47-55.
[30]	Huellner MW, Appenzeller P, Kuhn FP, et al. Whole-body nonenhanced PET/MR versus PET/CT in the staging and restaging of cancers: preliminary observations[J]. Radiology, 2014, 273(9): 859-69.
[31]	Rodrigues RS, Bozza FA, Christian PE, et al. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck[J]. J Nucl Med, 2009, 50(8): 1205-13. doi: 10.2967/jnumed.109.062075